| INCOME PER SHARE OF COMMON STOCK |
NOTE 13 - INCOME PER SHARE OF COMMON STOCK: The following table summarizes the calculation of basic and diluted income per common stock (in thousands, except for share and per share amounts): | | | Nine months ended | | | Three months ended | | | | | September 30, 2026 | | | September 30, 2025 | | | September 30, 2026 | | | September 30, 2025 | | | Basic income per common stock (numerator): | | | | | | | | | | | | | | Net income | | | 134,876 | | | | 54,041 | | | | 18,410 | | | | 48,395 | | | Adjustment for earnings allocated to participating unvested RSAs | | | (50 | ) | | | - | | | | (20 | ) | | | - | | | Net income applicable to common stock – basic | | | 134,826 | | | | 54,041 | | | | 18,390 | | | | 48,395 | | | common stock (denominator): | | | | | | | | | | | | | | | | | | Weighted average number of common stock – basic | | | 41,168,426 | | | | 41,569,359 | | | | 41,664,380 | | | | 41,756,301 | | | Basic income per common stock | | | 3.28 | | | | 1.30 | | | | 0.44 | | | | 1.16 | | | | | | | | | | | | | | | | | | | | | Diluted income per common stock (numerator): | | | | | | | | | | | | | | | | | | Net income | | | 134,876 | | | | 54,041 | | | | 18,410 | | | | 48,395 | | | Adjustment for earnings allocated to participating unvested RSAs | | | (48 | ) | | | | | | | (19 | ) | | | | | | Net income applicable to common stock – Diluted | | | 134,828 | | | | | | | | 18,391 | | | | | | | common stock (denominator): | | | | | | | | | | | | | | | | | | Weighted average number of common stock – basic | | | 41,168,426 | | | | 41,569,359 | | | | 41,664,380 | | | | 41,756,301 | | | Diluted effect of Options, RSUs, PSUs and RSAs | | | 1,336,010 | | | | 1,400,160 | | | | 1,350,937 | | | | 1,018,203 | | | Weighted average number of common stock – diluted | | | 42,504,437 | | | | 42,969,519 | | | | 43,015,317 | | | | 42,774,504 | | | Diluted income per common stock | | | 3.17 | | | | 1.26 | | | | 0.43 | | | | 1.13 | | For the nine months and three months ended September 30, 2026, options to purchase common stock and warrants totaling 1,461,128 and 1,766,617, respectively were excluded from the calculation of diluted income per common stock, as their effect was antidilutive. For the nine months and three months ended September 30, 2025, options to purchase common stock and warrants totaling 1,410,533 and 1,469,908, respectively were excluded from the calculation of diluted income per common stock, as their effect was antidilutive.
|